Navigation Links Added New Report on Levocarnitine (CAS 541-15-1) Market to Its Catalogue

London, UK (PRWEB) September 27, 2013 announces that a new research report on the levocarnitine (CAS 541-15-1) market created by BAC Reports is available in its catalogue.

The newly published report, “Levocarnitine (CAS 541-15-1) Market Research Report 2013,” draws up an elaborate picture of the levocarnitine market. It presents a comprehensive product profile, which contains levocarnitine’s description, a review of its composition and ingredients, information on the main health risks, insight into toxicological and ecological effects of the chemical, and a variety of handling, storage and transportation requirements. The research study presents an overview of levocarnitine’s properties, discusses the major production methods and details major applications of the product.

The study presents in-depth insights into the levocarnitine market globally and across major regions, and offers detailed profiles of the leading and niche manufacturers and traders active in the levocarnitine marketplace on a global and regional scale. Additionally, the report provides a snapshot of the key consumers of levocarnitine across key end-use sectors, besides looking into pricing issues by region.

Report Details:

Title: Levocarnitine (CAS 541-15-1) Market Research Report 2013
Published: September, 2013
Price: US$ 2,650.00

The geographical markets covered in the report are as follows: Asia, Europe, and North America.

The companies profiled in the research study include: Acros Organics B.V.B.A., Merck KGaA, Lonza A.G., Abtonsmart Chemicals Co., Ltd., Mira Biotechnology Co., Ltd., Nanchang Polis Bio-Tech Co., Ltd., Sunrise Chemical Co., Ltd, Suntran Industrial Group Ltd., Finetech Industry Limited, Biocon, Watanabe Chemical Industries International, Hubei Maxpharm Industries Co., Ltd., Tokyo Chemical Industry Co., Ltd., Toronto Research Chemicals Inc., Wonda Science Inc., Advanced ChemTech, and EMD Millipore Corporation, amid many others.

Reasons to Buy:

  •     The report is a source of critical information on the global levocarnitine market.
  •     Comprehensive product profile enriches one’s knowledge of levocarnitine, enabling to take informed business decisions.
  •     Insights into the levocarnitine market and data on the regional prices assist in identifying the most promising markets as well as in planning effective business strategies.
  •     Examination of the competitive environment helps to evaluate the level of competition within the market and thereby gain a competitive advantage over the rivals.
  •     Detailed profiles of the companies operating in the levocarnitine market contain all the information required to find prospective business partners.

More CAS chemicals reports by the publisher can be found at BAC Reports page.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Global Cancer Diagnostics Market to Witness Robust Growth, According to VPG Report Published at
2. Polyhydroxyalkanoate Demand to Grow Significantly in Future, According to M&M Study Published at
3. Added New Report on Hydroxyethyl Starch (CAS 9005-27-0) Market to Its Catalogue
4. Added New Report on Povidone Iodine (CAS 25655-41-8) Market to Its Catalogue
5. Added New Report on Mannitol (CAS 87-78-5) Market to Its Catalogue
6. Added New Report on 1-Ethynyl-1-cyclohexanol (CAS 78-27-3) Market to Its Catalogue
7. Aloe Vera Market Reviewed in Topical Research Study by BAC Reports Published at
8. Added New Report on 1,5-Diaminopentane (1,5-Pentanediamine) (CAS 462-94-2) Market to Its Catalogue
9. Added New Report on Ceramide (CAS 100403-19-8) Market to Its Catalogue
10. Added New Report on 1,2-Diaminopropane (CAS 78-90-0) Market to Its Catalogue
11. Added New Report on Hydroquinone (CAS 123-31-9) Market to Its Catalogue
Post Your Comments:
(Date:10/11/2017)... Bay, Florida (PRWEB) , ... October 11, 2017 ... ... and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel ... (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the cell ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO of ... Rotary Club. The event entitled “Stem Cells and Their Regenerative Powers,” ... Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, ...
(Date:10/10/2017)... Oct. 10, 2017 SomaGenics announced the receipt ... to develop RealSeq®-SC (Single Cell), expected to be the ... RNAs (including microRNAs) from single cells using NGS methods. ... need to accelerate development of approaches to analyze the ... "New techniques for measuring levels of mRNAs in ...
Breaking Biology Technology:
(Date:4/5/2017)... YORK , April 5, 2017 Today ... is announcing that the server component of the HYPR ... known for providing the end-to-end security architecture that empowers ... HYPR has already secured over 15 million ... makers including manufacturers of connected home product suites and ...
(Date:3/30/2017)... March 30, 2017  On April 6-7, 2017, ... Genome hackathon at Microsoft,s headquarters in ... will focus on developing health and wellness apps that ... Hack the Genome is the first hackathon for ... world,s largest companies in the genomics, tech and health ...
(Date:3/28/2017)... 2017 The report "Video Surveillance ... Servers, Storage Devices), Software (Video Analytics, VMS), and Service ... Forecast to 2022", published by MarketsandMarkets, the market was ... projected to reach USD 75.64 Billion by 2022, at ... base year considered for the study is 2016 and ...
Breaking Biology News(10 mins):